30th Apr 2024 Sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer- a plain language summary of the TROPHY-U-01 study
25th Jan 2024 The TROPiCS-02 study: a plain language summary on the effectiveness of sacituzumab govitecan in treating HR-positive/HER2-negative breast cancer
14th Nov 2023 A plain language summary of the ARROW study: pralsetinib in patients with RET fusion–positive non-small cell lung cancer
23rd May 2023 Plain Language Summary: tepotinib, a treatment for a subtype of non-small cell lung cancer called MET exon 14 skipping